Thursday,
September 25th |
|
|
11:30am – 1:00pm |
Update
on Emerging Strategies to Treat GIST and Overcome Resistance1
CME Satellite Symposium and Lunch |
|
|
1:15pm - 1:20pm |
Introduction
and ISGIO Presidential Inauguration |
|
Al Benson,
President |
|
|
1:20pm - 1:25pm |
Welcome
Remarks by the President |
|
New
President |
|
|
Session 1: Esophageal Cancer |
Chairpersons:
Atsushi Ohtsu, Mary McAleer |
|
|
1:25pm - 1:40pm |
Epidemiology
and Biology of Esophageal Cancer |
|
Steven DeMeester |
|
|
1:40pm - 1:45pm |
Q
and A |
|
|
1:45pm - 2:00pm |
Principles
of Modern Radiation Techniques for Esophageal and Gastroesophageal Junction
Cancers |
|
Gary Yang |
|
|
2:00pm - 2:05pm |
Q
and A |
|
|
2:05pm - 2:25pm |
Case
Presentations: Management of Esophageal Cancer and Barrett's Esophagus |
|
|
|
Case
Discussion 1: |
|
Locally
Advanced Esophageal Cancer
Mary McAleer |
|
|
|
Case
Discussion 2: |
|
EMR
Before or After Radiation
Atsushi Ohtsu |
|
|
|
Case
Discussion 3: |
|
Barrett’s
Dysplasia Treated with an Ablative Approach
Lopa Mishra |
|
|
2:25pm - 2:35pm |
Break |
|
|
2:35pm - 2:55pm |
Proffered
Papers |
|
|
2:55pm - 3:00pm |
Panel
Discussion With Interactive Q/A |
|
Moderator:
Steven DeMeester |
|
Panelists: Mary McAleer, Gary Yang, Jaffer Ajani, Atsushi Ohtsu,
Lopa Mishra |
|
|
Session 2: Pancreatic Cancer |
Chairpersons:
Malcolm Moore, Weijing Sun |
|
|
3:00pm - 3:15pm |
Molecular
Biology of Pancreatic Cancer |
|
James Abbruzzese |
|
|
3:15pm - 3:20pm |
Q
and A |
|
|
3:20pm - 3:35pm |
New
Strategies for Success in Pancreatic Cancer |
|
Eileen
O’Reilly |
|
|
3:35pm - 3:40pm |
Q
and A |
|
|
3:40pm - 4:00pm |
Case
Discussions: Localized and Metastatic Pancreatic Cancer |
|
|
|
Case
Discussion 1: |
|
Metastatic
First-Line
Philip Philip |
|
|
|
Case
Discussion 2: |
|
Locally
Advanced
Weijing Sun |
|
|
4:00pm - 4:40pm |
Proffered
Papers |
|
|
4:40pm - 5:00pm |
Panel
Discussion With Interactive Q/A |
|
Moderator:
Leonard Gunderson |
|
Panelists:
James Abbruzzese, Michael Choti, Malcolm Moore, Eileen O’Reilly, Philip
Philip, Weijing Sun, Gauri Varadhachary |
|
|
5:00pm – 7:15pm |
Biology and
Therapeutic Approaches in the Management of Hepatocellular Carcinoma2
CME Satellite Symposium and Dinner
|
|
|
7:15pm - 8:30pm |
Presidential
Session
You Treat My Patients: An ISGIO Teaching Course for
Fellows and Junior Practitioners
Chairpersons: Al Benson and the New President
Keynote Position Presentation: “The Need to Change
the Registration of Clinical Trials in GI Oncology - An Update of the ARCAD
Group Initiative”
Aimery de Gramont |
| |
|
| |
Case Presentations
Jaffer Ajani |
| |
Rectal cancer (localized disease for preop and postop situation) |
| |
Metastatic colon cancer (frontline, second line and third line therapy, and
potentially curable situation) |
| |
Pancreatic cancer (localized [resectable, borderline resectable, and unresectable]
and metastatic cancer [frontline and second line]) |
| |
Gastric cancer (localized [preop therapy and postop therapy] and
metastatic [frontline, second line] |
| |
Esophageal cancer (localized squamous and adenocarcinoma, early esophageal
cancer, and unresectable esophageal cancer, HGD in Barrett’s) |
| |
Anal cancer (one case) |
| |
Hepatocellular (localized, unresectable, second line therapy) |
| |
Gall bladder cancer (resected T3 N1) |
| |
Panelists: Ghassan Abou-Alfa, Johanna Bendell, Al Benson, Prajnan
Das, Aimery de Gramont, Michael Choti, Leonard Gunderson, David Ryan, Steven DeMeester,
James Hayman, John Marshall, Edith Mitchell, Philip A. Philip, Leonard Saltz,
Sandra Wong |
|
|
Friday,
September 26th |
|
Session 3: Advanced Colorectal Cancer |
Chairpersons:
Aimery de Gramont, John Marshall, Sandra Wong |
|
|
8:00am - 8:15am |
New
Agents on the Horizon: Positioning Them for Advantage |
|
Leonard Saltz |
|
|
8:15am - 8:20am |
Q
and A |
|
|
8:20am - 8:35am |
Curable
Metastatic Colorectal Cancer |
|
William Jarnagin |
|
|
8:35am - 8:40am |
Q
and A |
|
|
8:40am - 9:40am |
Case
Presentations |
|
|
|
Case
Discussion 1: |
|
First-Line
Advanced
John
Marshall |
|
|
|
Case
Discussion 2: |
|
Metastatic
but Potentially Curable
Axel Grothey |
|
|
|
Case
Discussion 3: |
|
Second-Line
and Third-Line
Leonard Saltz |
|
|
9:40am - 10:20am |
Proffered
Papers |
|
|
10:20am - 11:00am |
Panel
Discussion With Interactive Q/A |
|
Moderator:
Yasuhide Yamada |
|
Panelists:
Aimery de Gramont, Axel Grothey, Leonard Saltz, William Jarnagin, John
Marshall, Sandra Wong |
|
|
|
|
11:00am – 1:00pm |
Moving
Towards New Treatment Paradigms in Metastatic Colorectal Cancer3
CME
Satellite Symposium and Lunch |
|
|
Session 4: Hepatobiliary Cancer |
Chairpersons:
Michael Choti, Ghassan Abou-Alfa, Melanie Thomas |
|
|
1:00pm - 1:40pm |
Case
Presentations |
|
|
|
Case
Discussion 1: |
|
First-Line
Therapy for Advanced HCC
Ghassan Abou-Alfa |
|
|
|
Case
Discussion 2: |
|
Patient
Who Had a Transplant
Michael Choti |
|
|
|
Case
Discussion 3: |
|
Second-Line
Therapy for Advanced HCC
Melanie Thomas |
|
|
1:40pm - 1:50pm |
Proffered
Papers |
|
|
1:50pm - 2:00pm |
Break |
|
|
Session 5: Emerging Science |
Chairpersons:
Lopa Mishra, Eunice Kwak |
|
|
2:00pm - 2:25pm |
Keynote
Presentation: Molecular Origins of Cancer |
|
Lynda Chin |
|
|
2:25pm - 2:35pm |
Q
and A |
|
|
2:35pm - 2:50pm |
Understanding
Biostatistics and Informatics |
|
Mithat Gönen |
|
|
2:50pm - 2:55pm |
Q
and A |
|
|
2:55pm - 3:10pm |
Circulating
Tumor Cells |
|
Eunice Kwak |
|
|
3:10pm - 3:15pm |
Q
and A |
|
|
3:15pm - 3:50pm |
Panel
Discussion With Interactive Q/A |
|
Moderator:
Lopa Mishra |
|
Panelists:
Eunice Kwak, Mithat Gönen, Lynda Chin |
|
|
Session 6: Adjuvant Colon Cancer |
Chairpersons:
Al Benson, David Ryan |
|
|
3:50pm - 4:05pm |
Adjuvant
Therapy of Colon Cancer: Lessens Learned and Challenges Ahead |
|
Norman Wolmark |
|
|
4:05pm - 4:10pm |
Q
and A |
|
|
4:10pm - 4:50pm |
Case
Presentations |
|
|
|
Case
Discussion 1: |
|
Stage
II
Johanna Bendell |
|
|
|
Case
Discussion 2: |
|
Stage
III
John Marshall |
|
|
|
Case Discussion
3: |
|
Stage
II With Wild Type K-ras
Axel Grothey |
|
|
|
Case
Discussion 4: |
|
Stage
IVa After Primary Surgery for Synchronous Liver Metastases-Previously
Untreated
Axel Grothey |
|
|
